PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF), a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, began trading on the OTCQB Venture Market on October 19, 2021.
“We are extremely excited to be posting our shares on the OTCQB, a well-known U.S. Securities platform. We believe the strategy to increase U.S. investor ownership fits well with the growing focus on biotech research and development as well as the Company’s intention to both lead and collaborate on several FDA clinical trials.”
Daniel Cohen, CEO, PharmaDrug
U.S. investors can view current financial disclosures and real-time Level 2 quotes at www.otcmarkets.com as well as more information on www.pharmadrug.ca.
